María Fernanda Lara

Dr. María Fernanda Lara

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
IMInmaculada Moreno
Inmaculada Moreno
DCDaniel Castellano-Castillo
Daniel Castellano-Castillo
MLMaría Fernanda Lara
María Fernanda Lara
JFJose C. Fernandez-Garcia
Jose C. Fernandez-Garcia
FTFrancisco Tinahones
Francisco Tinahones
MMManuel Macias-Gonzalez
Manuel Macias-Gonzalez
Adipose tissue has traditionally only been considered as an energy storage organ. Nevertheless, the importance of this tissue in systemic physiology and, especially, in systemic inflammation has been highlighted in recent years. Adipose tissue expresses proteins related to vitamin D (VD) metabolism, and it has been proposed that it can act as a VD storage tissue. The active form of VD, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), is able to modify adipocyte and adipose tissue physiology via the VD receptor (VDR), decreasing the expression of pro-inflammatory cytokines in adipose tissue. Moreover, VD deficiency and VDR has been reported to be associated with obesity and diabetes. However, the results of the different studies are not conclusive. Insulin growth binding proteins (IGFBPs) have been identified in adipose tissue, but their roles are poorly understood. Therefore, the objective of this study was to analyze the plasma levels of VD and the gene expression of VDR in the adipose tissue of subjects with morbid obesity (MO) and with different degrees of insulin resistance (IR), as well as the functionality of direct interaction between IGFBP-3 and VDR, which could explain its inhibitory role in adipogenesis. Our results show a novel role of the VD system in the regulation and activation of IGFBP-3 in visceral adipose tissue (VAT) of patients with MO, as a new and alternative mechanism proposed in the insulin signaling associated with obesity.

1 August 2015 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
JGJaime Gomez-Millan
Jaime Gomez-Millan
MLMaría Fernanda Lara
María Fernanda Lara
RGRaquel Correa Generoso
Raquel Correa Generoso
APAlberto Perez-Rozos
Alberto Perez-Rozos
YLYolanda Lupiáñez-Pérez
Yolanda Lupiáñez-Pérez
JCJose Antonio Medina Carmona
Jose Antonio Medina Carmona

9 May 2016 in EPMA Journal
Verified
Journal Article
Open access
PDF file
JAJella-Andrea Abraham
Jella-Andrea Abraham
OGOlga Golubnitschaja
Olga Golubnitschaja
IAIldar Akhmetov
Ildar Akhmetov
RARussell J. Andrews
Russell J. Andrews
LQLeonidas Quintana
Leonidas Quintana
MÖMeral Özgüç
Meral Özgüç
A1 Predictive and prognostic biomarker panel for targeted application of radioembolisation improving individual outcomes in hepatocellular carcinoma Jella-

22 March 2005 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
MSMirentxu Santos
Mirentxu Santos
PRPaula Rio
Paula Rio
SRSergio Ruiz
Sergio Ruiz
JMJesús Martínez-Palacio
Jesús Martínez-Palacio
CSCarmen Segrelles
Carmen Segrelles
JESÚS M ParamioJESÚS M Paramio
JESÚS M Paramio

9 November 2012 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CCClotilde Costa
Clotilde Costa
MSMirentxu Santos
Mirentxu Santos
CSCarmen Segrelles
Carmen Segrelles
MDMarta Dueñas
Marta Dueñas
MLMaría Fernanda Lara
María Fernanda Lara
JESÚS M ParamioJESÚS M Paramio
JESÚS M Paramio
The specific ablation of Rb1 gene in stratified epithelia (RbF/F;K14cre) promotes proliferation and altered differentiation but is insufficient to produce spontaneous tumors. The pRb relative, p107, compensates some of the functions of pRb in these tissues; however, RbF/F;K14cre;p107−/− mice die postnatally. Here we show, using an inducible mouse model (RbF/F;K14creERTM), that p107 exerts specific tumor suppressor functions in the absence of pRb in stratified epithelia. The simultaneous absence of pRb and p107 produces impaired p53 transcriptional functions and reduction of Pten expression, allowing spontaneous squamous carcinoma development. These tumors display significant overlap with human squamous carcinomas, supporting that RbF/F;K14creERTM;p107−/− mice might constitute a new model for these malignancies. Remarkably tumor development in vivo is partially alleviated by mTOR inhibition. These data demonstrate the existence of a previously unreported functional connection between pRb, Pten and p53 tumor suppressors, through p107, of a particular relevance in squamous tumor development.

7 November 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
LGLucía García-Morales
Lucía García-Morales
FCFrancisco Javier Contreras-Matos
Francisco Javier Contreras-Matos
ABAna Blanca
Ana Blanca
AMAlejandro Mellado-Castillero
Alejandro Mellado-Castillero
JHJuan Pablo Campos Hernández
Juan Pablo Campos Hernández
EGEnrique Gomez Gomez
Enrique Gomez Gomez
Background/Objectives: A retrospective analysis was conducted to identify factors associated with disease progression and intravesical recurrence (IVR) in a multi-centre cohort of patients with upper urinary tract urothelial carcinoma (UTUC) treated surgically between 2015 and 2021. Methods: Progression-free survival (PFS) and IVR-free survival were evaluated using a Kaplan–Meier survival curve and a Log-Rank test. Prognostic factors for progression and IVR were analysed using Cox logistic regression analysis. Results: A total of 170 patients were analysed. Up to 32.9% developed progression within 65.64 ± 3.44 months. Multivariate analysis showed that pT (HR 2.9, 95%CI 1.54–5.48, p = 0.01), margin status (HR 2.89, 95%CI 2.88–57.68, p = 0.01), and lymphovascular involvement (HR 7.97, 95% CI 1.43–44.42, p = 0.02) were independent risk factors for PFS. Up to 25.9% of patients presented with IVR at a mean time of 68.33 ± 3.59 months. A previous diagnosis of bladder cancer (BC) (HR 3.73, 95% CI 1.24–11.22, p = 0.02) and the non-invasive appearance of the tumour on computed tomography were significant risk factors for IVR (HR 0.23, 95% CI 0.05–0.95, p = 0.03). Conclusions: pT stage, margin involvement, and lymphovascular involvement were independent risk factors for UTUC progression. The main risk factor for presenting with IVR after UTUC was a previous diagnosis of BC.